All
Research
Education
연구
교육
Business
솔루션
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
로그인
Department of Rheumatology,
Fujian Institute of Clinical Immunology,
Department of Rheumatology, Fujian Institute of Clinical Immunology
Jixin Zhong has not added Biography.
If you are Jixin Zhong and would like to personalize this page please email our Author Liaison for assistance.
JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization.
International immunopharmacology Jul, 2023 | Pubmed ID: 37269741
Immunomodulatory effects of iTr35 cell subpopulation and its research progress.
Clinical and experimental medicine Feb, 2024 | Pubmed ID: 38386086
Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates.
Pharmacological reviews Jun, 2024 | Pubmed ID: 38622001
Mid1 promotes synovitis in rheumatoid arthritis via ubiquitin-dependent post-translational modification.
Pharmacological research Jul, 2024 | Pubmed ID: 38777113
Deciphering the therapeutic potential of Myeloid-Specific JAK2 inhibition in acute respiratory distress syndrome.
Mucosal immunology Dec, 2024 | Pubmed ID: 39173745
Fujian Medical University Union Hospital
Huazhong University of Science and Technology
Ministry of Education
Zijun Ma1,2,
Na Zheng2,
Yingying Wei1,2,
Jixin Zhong1,2,3
1Department of Rheumatology, Fujian Institute of Clinical Immunology, Fujian Medical University Union Hospital,
2Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,
3Key Laboratory of Vascular Aging (HUST), Ministry of Education
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
저자
사서
액세스
JoVE 소개
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. 판권 소유